Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Report: Global Pharmaceutical Market Remains in Declining Growth Trend

By Pharmaceutical Processing | May 5, 2011

Decision Resources, a research and advisory firm for pharmaceutical
and healthcare issues, finds that in 2010, the global pharmaceutical market
continued to show declining growth. According to new data from Decision
Resources’ Pharmaview suite, global pharmaceutical sales grew year-over-year by
a mere 3.2 percent to reach $669 billion, compared with 3.5 percent
year-over-year growth in 2009 and 7.5 percent year-over-year growth in 2008.
Over the next seven years, the global market is expected to record a compound
annual growth rate (CAGR) of 2.2 percent, reaching $778 billion in 2017.

In the United
States, sales continued to stagnate, with
0.7 percent year-over-year growth in 2010, increasing to $283 billion. The U.S. market
will continue to idle, with an expected CAGR of 1.7 percent between 2010 and
2017, reaching $318 billion in 2017.

“The limited growth is not surprising as patent
expires, payer cost-containment strategies and lack of research and development
productivity continue to negatively impact the pharmaceutical market,” said
Decision Resources’ Pharmaview Director Alasdair Milton, Ph.D.

“In response, many large pharmaceutical companies are
revamping R&D efforts, diversifying their business models into consumer
health and generics, and collaborating with small biotechs and peer companies.

They are also looking at emerging markets; while the sheer
size of patient numbers involved make these geographies attractive targets, companies
should realize that doing business in these areas poses its own unique
challenges.” The sales findings are from the most recent release of
Decision Resources’ Pharmaview, which assesses the commercial aspect of the global
pharmaceutical market and provides continually updated analysis of more than
2,200 drugs from more than 240 companies, covering 150 product classes and 14
therapy areas. Pharmaview also provides company profiles on the leading players
in the pharmaceutical market, recently adding Otsuka to its coverage.

  

Related Articles Read More >

Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE